Written Question·Department of Health and Social Care·UIN 23967

Givinostat

Tabled: 14 January 2025

Answered: 20 January 2025

Question

Martin Wrigley

To ask the Secretary of State for Health and Social Care, if he will have discussions with NICE on the potential merits of offering Givinostat for Duchenne muscular dystrophy.

Answer

Karin Smyth

There are no plans to have discussions with the National Institute for Health and Care Excellence (NICE) on offering givinostat for Duchenne muscular dystrophy. The NICE makes recommendations for the National Health Service on whether new licensed medicin...

ⓘ

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 23967) →

Partner sites